Oral microparticulate vaccine for melanoma using M-cell targeting

Journal of Drug Targeting

Volumn 20, Issue 2, 2012, Pages 166-173

  D'Souza, Bernadette ^a   Bhowmik, Tuhin ^a   Shashidharamurthy, Rangaiah ^b   Oettinger, Carl ^a   Selvaraj, Periasamy ^b   D'Souza, Martin ^a  

^a SAMFORD UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Albumin; Aleuria aurantia lectin; Immunogenicity; Spray drying targeting; Tumor volume

Indexed keywords

ALEURIA AURANTIA LECTIN; IMMUNOGLOBULIN G; LECTIN; MELANOMA ANTIGEN; MELANOMA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CANCER IMMUNIZATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG TARGETING; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CONTENT; SURFACE CHARGE; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ALBUMINS; ANIMALS; CANCER VACCINES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; IMMUNOGLOBULIN G; LECTINS; MELANOMA; MICE; MICE, INBRED DBA; MICROSPHERES; PARTICLE SIZE; PEYER'S PATCHES; SURFACE PROPERTIES;

EID: 84855662860     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.622395     Document Type: Article

References (39)

1. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release, 79, 29-40. (Pubitemid 34164159)
2. Akande J, Yeboah KG, Addo RT, Siddiq A, Oettinger CW, D'Souza MJ. (2010). Targeted delivery of antigens to the gut associated lymphoid tissues. J Microencapsul, 27, 325-336.
3. Balashova E, Lokhov P. (2010). Cellular cancer vaccines: An update on the development of vaccines generated from cell surface antigens. Journal of Cancer, 1, 230-241.
4. Banchereau J, Steinman RM. (1998). Dendritic cells and the control of immunity. Nature, 392, 245-252. (Pubitemid 28155090)
5. Benencia F, Courrèges MC, Conejo-García JR, Mohammed-Hadley A, Coukos G. (2006). Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity. Cancer Biol Ther, 5, 867-874. (Pubitemid 44794029)
6. Bramwell VW, Perrie Y. (2005). Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst, 22, 151-214. (Pubitemid 41557321)
7. Brown WR. (1996). Enteric immunization: Promises and challenges. Dig Dis, 14, 192-200. (Pubitemid 126477818)
8. Bumgarner GW.2002). Evaluation of the microparticle as an adjuvant or coadjuvant in a tumor vaccine. Ph.D Thesis Mercer University, US
9. Bye WA, Allan CH, Trier JS. (1984). Structure, distribution, and origin of M cells in Peyer's patches of mouse ileum. Gastroenterology, 86, 789-801. (Pubitemid 14132457)
10. Chen H, Torchilin V, Langer R. (1996). Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm Res, 13, 1378-1383. (Pubitemid 26344985)
11. Chowdhury S, Vaughan MM, Gore ME. (1999). New approaches to the systemic treatment of melanoma. Cancer Treat Rev, 25, 259-270. (Pubitemid 29507297)
12. Ciftci K, Trovitch P. (2003). Current approaches in the treatment of melanoma-II: Immune-and gene therapy. Turk J Canc, 33, 127-136. (Pubitemid 38313388)
13. Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH. (2001). Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine, 20, 208-217. (Pubitemid 32905334)
14. Clark MA, Jepson MA, Hirst BH. (2001). Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev, 50, 81-106. (Pubitemid 32727278)
15. Copier J, Dalgleish A. (2006). Overview of tumor cell-based vaccines. Int Rev Immunol, 25, 297-319. (Pubitemid 44972269)
16. Crennell S, Garman E, Laver G, Vimr E, Taylor G. (1994). Crystal structure of Vibrio cholerae neuraminidase reveals dual lectinlike domains in addition to the catalytic domain. Structure, 2, 535-544.
17. D'Souza MJ, DeSouza PJ. (1995). Site specific microencapsulated drug targeting strategies to the liver and the gastrointestinal tract. Adv Drug Delivery Reviews, 17, 247-254.
18. D'Souza MJ, Pourfarzib R. (1999). Improved efficacy of a microencapsulated macrophage colony stimulating factor and methotrexate in melanoma. Drug Dev Ind Pharm, 25, 583-590. (Pubitemid 29186289)
19. Doyle K, Beer S, Vorhies P. (2010). The ongoing hopes and challenges of cancer. Oncology business review, 1, 26-30.
20. Franziska RW, Bohle B, Scholl I, Untersmayr E, Gaborf F, Jensen-Jarolim E. (2005). Targeting antigens to muirine and human M cells with Aleuria aurantia lectin-functionalized microparticles. Immunol Letters, 100, 182-188. (Pubitemid 41262018)
21. Foged C, Brodin B, Frokjaer S, Sundblad A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm, 298, 315-322. (Pubitemid 40910735)
22. Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D'Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-αB encapsulated albumin microspheres. J Microencapsul, 26, 692-700.
23. Genta I, Perugini P, Pavanetto F, Modena T, Conti B, Muzzarelli RA. (1999). Microparticulate drug delivery systems. EXS, 87, 305-313.
24. Goldsby RA, Kindt TJ, Osborne BA. 2000). Kuby Immunology. WH. Freeman and Company Publisher and Distributor: NY.
25. Malik B, Goyal AK, Mangal S, Zakir F, Vyas SP. (2010). Implication of gut immunology in the design of oral vaccines. Curr Mol Med, 10, 47-70.
26. Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. (2009). Albuminbound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine, 4, 99-105.
27. Morton DL, Foshag LJ, Hoon DS, Nizze JA, Famatiga E, Wanek LA, Chang C, Davtyan DG, Gupta RK, Elashoff R. (1992). Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg, 216, 463-482.
28. Morton DL, Barth A. (1996). Vaccine therapy for malignant melanoma. CA Cancer J Clin, 46, 225-244. (Pubitemid 26254105)
29. O'Hagan DT. (1998). Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Deliv Rev, 34, 305-320. (Pubitemid 28535117)
30. Peter I, Mezzacasa A, LeDonne P, Dummer R, Hemmi S. (2001). Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3. Melanoma Res, 11, 21-30. (Pubitemid 32158182)
31. Slaper H, Velders GJ, Daniel JS, de Gruijl FR, van der Leun JC. (1996). Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature, 384, 256-258. (Pubitemid 26396972)
32. Tabata Y, Ikada Y. (1988). Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 9, 356-362.
33. Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D'Souza MJ. (2009). Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target, 17, 553-560.
34. Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S. (2002). Immunotherapeutic potential of whole tumour cells. Cancer Immunol Immunother, 51, 351-357. (Pubitemid 35002039)
35. Wu Y, Wang X, Csencsits KL, Haddad A, Walters N, Pascual DW. (2001). M cell-targeted DNA vaccination. Proc Natl Acad Sci USA, 98, 9318-9323. (Pubitemid 32743914)
36. Weinstein DL, O'Neill BL, Hone DM, Metcalf ES. (1998). Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Infect Immun, 66, 2310-2318. (Pubitemid 28194135)
37. Wolf JL, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, Trier JS, Fields BN. (1981). Intestinal M cells: A pathway for entry of reovirus into the host. Science, 212, 471-472. (Pubitemid 11041943)
38. Lai YH, D'Souza MJ. (2007). Formulation and evaluation of an oral melanoma vaccine. J Microencapsul, 24, 235-252. (Pubitemid 46567407)
39. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H. (1997). Antigen localisation regulates immune responses in a doseand time-dependent fashion: A geographical view of immune reactivity. Immunol Rev, 156, 199-209. (Pubitemid 27197203)